» Articles » PMID: 39766245

Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with SsDNA

Overview
Journal Biomolecules
Publisher MDPI
Date 2025 Jan 8
PMID 39766245
Authors
Affiliations
Soon will be listed here.
Abstract

The nucleocapsid (N) protein is one of the four structural proteins in SARS-CoV-2, playing key roles in viral assembly, immune evasion, and stability. One of its primary functions is to protect viral RNA by forming the nucleocapsid. However, the precise mechanisms by which the N protein interacts with viral RNA and assembles into a nucleocapsid remain unclear. Compared to other SARS-CoV-2 components, targeting the N protein has several advantages: it exhibits higher sequence conservation, lower mutation rates, and stronger immunogenicity, making it an attractive target for antiviral drug development and diagnostics. Therefore, a detailed understanding of the N protein's structure is essential for deciphering its role in viral assembly and developing effective therapeutics. In this study, we report the expression and purification of a soluble recombinant N protein, along with a 1.55 Å resolution crystal structure of its nucleic acid-binding domain (N-NTD) in complex with ssDNA. Our structure revealed new insights into the conformation and interaction of the flexible N-arm, which could aid in understanding nucleocapsid assembly. Additionally, we identified residues that are critical for ssDNA interaction.

References
1.
Arya R, Kumari S, Pandey B, Mistry H, Bihani S, Das A . Structural insights into SARS-CoV-2 proteins. J Mol Biol. 2020; 433(2):166725. PMC: 7685130. DOI: 10.1016/j.jmb.2020.11.024. View

2.
Jayaram H, Fan H, Bowman B, Ooi A, Jayaram J, Collisson E . X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol. 2006; 80(13):6612-20. PMC: 1488953. DOI: 10.1128/JVI.00157-06. View

3.
Eltayeb A, Al-Sarraj F, Alharbi M, Albiheyri R, Mattar E, Abu Zeid I . Overview of the SARS-CoV-2 nucleocapsid protein. Int J Biol Macromol. 2024; 260(Pt 2):129523. DOI: 10.1016/j.ijbiomac.2024.129523. View

4.
Di D, Dileepan M, Ahmed S, Liang Y, Ly H . Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection. Pathogens. 2021; 10(8). PMC: 8402198. DOI: 10.3390/pathogens10081039. View

5.
Wingfield P . Overview of the purification of recombinant proteins produced in Escherichia coli. Curr Protoc Protein Sci. 2008; Chapter 6:6.1.1-6.1.37. DOI: 10.1002/0471140864.ps0601s30. View